NasdaqGM:ATRCMedical Equipment
A Look At AtriCure (ATRC) Valuation After Earnings Update Signals Profitability Shift
AtriCure (ATRC) recently issued a preliminary earnings update that pointed to a shift toward full year profitability in 2026, supported by guidance for revenue growth in the double digits and stronger adjusted EBITDA.
See our latest analysis for AtriCure.
The recent guidance and credit agreement amendment came after a sharp move higher around the earnings pre announcement. Yet the 1 year total shareholder return of 1.53% and 5 year total shareholder return of a 33.00% decline suggest only...